Chen CH - Search Results

1

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.

Choi WM, Yip TC, Wong GL, Kim WR, Yee LJ, Brooks-Rooney C, Curteis T, Cant H, Chen CH, Chen CY, Huang YH, Jin YJ, Jun DW, Kim JW, Park NH, Peng CY, Shin HP, Shin JW, Yang YH, Lim YS. Choi WM, et al. Among authors: chen ch, chen cy. J Hepatol. 2023 Mar;78(3):534-542. doi: 10.1016/j.jhep.2022.12.007. Epub 2022 Dec 23. J Hepatol. 2023. PMID: 36572349 Free article.

2

Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: role of viral infection.

Tai DI, Chen CH, Chang TT, Chen SC, Liao LY, Kuo CH, Chen YY, Chen GH, Yang SS, Tang HS, Lin HH, Lin DY, Lo SK, Du JM, Lin KC, Changchien CS, Chang WY, Sheu JC, Liaw YF, Chen DS, Sung JL. Tai DI, et al. Among authors: chen sc, chen yy, chen gh, chen ds, chen ch. J Gastroenterol Hepatol. 2002 Jun;17(6):682-9. doi: 10.1046/j.1440-1746.2002.02747.x. J Gastroenterol Hepatol. 2002. PMID: 12100614

3

Is delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy?

Hung CH, Lee CM, Lu SN, Wang JH, Tung HD, Chen TM, Chen CH, Changchien CS. Hung CH, et al. Among authors: chen ch, chen tm. J Gastroenterol Hepatol. 2002 Dec;17(12):1307-11. doi: 10.1046/j.1440-1746.2002.02874.x. J Gastroenterol Hepatol. 2002. PMID: 12423276

4

Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma.

Chen CH, Chen YY, Chen GH, Yang SS, Tang HS, Lin HH, Lin DY, Lo SK, Du JM, Chang TT, Chen SC, Liao LY, Kuo CH, Lin KC, Tai DI, Changchien CS, Chang WY, Sheu JC, Chen DS, Liaw YF, Sung JL. Chen CH, et al. Among authors: chen yy, chen sc, chen gh, chen ds. J Hepatol. 2004 Apr;40(4):653-9. doi: 10.1016/j.jhep.2003.12.002. J Hepatol. 2004. PMID: 15030982

5

Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants.

Chen CH, Lee CM, Lu SN, Wang JH, Tung HD, Hung CH, Chen WJ, Changchien CS. Chen CH, et al. Among authors: chen wj. J Hepatol. 2004 Sep;41(3):454-61. doi: 10.1016/j.jhep.2004.04.032. J Hepatol. 2004. PMID: 15336449 Clinical Trial.

6

The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study.

Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee PC, Lee HS, Lin PW, Huang GT, Sheu JC, Tsai HM, Chau GY, Chiang JH, Lui WY, Lee SD, Wu JC. Huang YH, et al. Among authors: chen sc, chen ch. Liver Int. 2004 Oct;24(5):419-24. doi: 10.1111/j.1478-3231.2004.0941.x. Liver Int. 2004. PMID: 15482337 Clinical Trial.

7

Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.

Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD. Huang YH, et al. Among authors: chen ch. Liver Int. 2005 Apr;25(2):236-41. doi: 10.1111/j.1478-3231.2005.01081.x. Liver Int. 2005. PMID: 15780044

8

Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.

Hung CH, Lee CM, Lu SN, Wang JH, Tung HD, Chen CH, Changchien CS. Hung CH, et al. Among authors: chen ch. J Gastroenterol Hepatol. 2005 May;20(5):727-32. doi: 10.1111/j.1440-1746.2005.03791.x. J Gastroenterol Hepatol. 2005. PMID: 15853986 Clinical Trial.

9

Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.

Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee HS, Lin PW, Huang GT, Sheu JC, Tsai HM, Lee PC, Chau GY, Lui WY, Lee SD, Wu JC. Huang YH, et al. Among authors: chen sc, chen ch. J Gastroenterol Hepatol. 2005 May;20(5):765-71. doi: 10.1111/j.1440-1746.2005.03746.x. J Gastroenterol Hepatol. 2005. PMID: 15853992

10

Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus.

Hung CH, Lee CM, Wang JH, Tung HD, Chen CH, Lu SN. Hung CH, et al. Among authors: chen ch. J Gastroenterol Hepatol. 2005 Oct;20(10):1553-9. doi: 10.1111/j.1440-1746.2005.03925.x. J Gastroenterol Hepatol. 2005. PMID: 16174073 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,786 results

Search Page